Profil
Stephen Mitchener worked as the Head of US Oncology Strategy, Partnering & Operations at Novartis Pharmaceuticals Corp.
from 2005 to 2018.
He then worked as the Chief Business Officer at Karyopharm Therapeutics, Inc. before becoming the Chief Business Officer & Senior Vice President at Axcella Health, Inc. from 2018 to 2020.
Mitchener holds a doctorate degree from The University of North Carolina at Charlotte.
Ehemalige bekannte Positionen von Stephen Mitchener
| Unternehmen | Position | Ende |
|---|---|---|
| AXCA HEALPAR | Corporate Officer/Principal | 01.12.2020 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01.08.2018 |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
Ausbildung von Stephen Mitchener
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axcella Health, Inc.
Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
















